How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group.

[1]  A. Barnadas,et al.  Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial. , 2007, Lung cancer.

[2]  C. Tajer,et al.  PD5-2-7: Hiperfractionated (HFRT) versus Standard Radiotherapy (SRT) in Locally Advanced (LA) NSCLC: a metaanalysis of randomized phase III trials , 2007 .

[3]  A. Russo,et al.  A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer , 2007, Anti-cancer drugs.

[4]  J. Herndon,et al.  Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  K. Ulm,et al.  Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Omar,et al.  Randomized study of concurrent carboplatin, paclitaxel, and radiotherapy with or without prior induction chemotherapy in patients with locally advanced non-small cell lung cancer. , 2006, Journal of the Egyptian National Cancer Institute.

[7]  C. Fuller,et al.  Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  M. Trovò,et al.  Thoracic radiation therapy and concomitant low-dose daily paclitaxel in non-small cell lung cancer: a phase I study. , 2005, Oncology reports.

[9]  J. Lester,et al.  Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review. , 2005, International journal of radiation oncology, biology, physics.

[10]  B. Jeremic,et al.  Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Walter J Curran,et al.  Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Mehta,et al.  Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Okunieff,et al.  Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  J. Jassem.  Combined chemotherapy and radiation in locally advanced non-small-cell lung cancer. , 2001, The Lancet. Oncology.

[15]  W. Curran,et al.  Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410 , 2000 .

[16]  J. Nyman,et al.  Accelerated radiotherapy with docetaxel and cisplatin as induction and concomitant chemotherapy for stage III non-small cell lung cancer , 2000 .

[17]  S. Kudoh,et al.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  D. Joseph,et al.  A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  J. Rigas,et al.  Daily paclitaxel and thoracic radiation therapy for non-small cell lung cancer: preliminary results. , 1999, Seminars in radiation oncology.

[20]  M. Parmar,et al.  Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial , 1997, The Lancet.

[21]  M. Quaia,et al.  Paclitaxel as a radiosensitiser: a proposed schedule of administration based on in vitro data and pharmacokinetic calculations. , 1997, European journal of cancer.

[22]  H. Bartelink,et al.  Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.

[23]  J. Cooper,et al.  Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. , 1991, International journal of radiation oncology, biology, physics.

[24]  R. Simon,et al.  Optimal two-stage designs for phase II clinical trials. , 1989, Controlled clinical trials.

[25]  Z. Petrovich,et al.  Cranial irradiation in cancer of the lung of all cell types. , 1981, JAMA.

[26]  E. Topuz,et al.  Induction and concurrent chemotherapy with concomitant boost radiotherapy in non-small cell lung cancer , 2005, Medical oncology.

[27]  B. Bergman,et al.  Accelerated hyperfractionated radiotherapy combined with induction and concomitant chemotherapy for inoperable non-small-cell lung cancer--impact of total treatment time. , 1998, Acta oncologica.

[28]  D. Booser,et al.  Combined chemoradiotherapy in limited-disease, inoperable non-small cell lung cancer. , 1988, International journal of radiation oncology, biology, physics.